BLACKROCK NORTH AMERICAN INCOME TRUST plc
All information is at 28 February 2015 and unaudited.
Performance at month end with net income reinvested
One Three Six Since
Month months months launch
(24 Oct 2012)
Net asset value 2.3% 2.5% 10.8% 38.8%
Share price 1.7% 1.9% 11.1% 28.4%
Russell 1000 Value Index 1.9% 2.6% 11.2% 59.4%
Source: BlackRock
At month end
Net asset value - capital only: 125.06p
Net asset value - cum income: 125.99p
Share price: 118.50p
Discount to cum income NAV: 5.9%
Net yield*: 3.4%
Total assets including current year revenue: £101.2m
Target yield: 4.0p
Gearing: nil
Options overwrite: 18.93%
Ordinary shares in issue: 80,289,044
Ongoing charges**: 1.3%
*Based on dividends of 1p per share each declared on 14 May 2014, 13 August
2014, 6 November 2014 and 12 February 2015.
** Ongoing charges represent the management fee and all other operating
expenses excluding interest as a % of average shareholders' funds for the year
ended 31 October 2014.
Benchmark
Sector Analysis Total Assets (%)
Financials 24.6
Industrials 16.0
Health Care 13.4
Energy 9.4
Consumer Discretionary 8.1
Information Technology 7.7
Consumer Staples 7.5
Utilities 5.8
Materials 5.1
Telecommunication Services 2.1
Net current assets 0.3
-----
100.0
=====
Country Analysis Total Assets (%)
USA 96.0
France 1.6
United Kingdom 1.0
Australia 0.6
Canada 0.3
Netherlands 0.2
Net current assets 0.3
-----
100.0
=====
Ten Largest Investments
Company Country of Risk Total Assets(%)
Wells Fargo USA 3.8
JPMorgan Chase USA 3.3
Home Depot USA 2.7
Comcast USA 2.7
General Electric USA 2.6
Pfizer USA 2.6
Microsoft USA 2.5
Merck USA 2.2
Raytheon USA 2.2
Bristol-Myers Squibb USA 2.0
Bob Shearer and Tony DeSpirito, representing the Investment Manager, noted:
Performance
For the one month period ended 28 February 2015 the Company's NAV increased by
2.3% while the share price increased by 1.7% (all in sterling terms with income
reinvested). The Company's benchmark, the Russell 1000 Value Index, increased
by 1.9% for the period.
The largest contributor to relative returns was stock selection in financials
as our underweight to real estate investment trusts ("REITs") and overweight to
the bank industry proved to be beneficial. Top portfolio contributors in
financials include our overweight to JPMorgan Chase (+9.5%) and Fifth Third
Bancorp (+8.8%). An underweight to utilities also added to relative
performance. Notably, the performance of utilities and REITs has been highly
correlated to long Treasury bonds in recent years and these sectors lagged
during February as interest rates trended higher.
The largest detractor from relative performance for the month was stock
selection in health care as our overweight to Merck and Bristol-Myers Squibb
proved to be costly. Other notable detractors included Diageo, a non-benchmark
holding in the beverages industry, and Intel, which lagged relative to
benchmark peers in the semiconductor industry.
Transactions/Options
Transactions: In February we increased our exposure to the information
technology sector by adding to existing positions in Microsoft and QUALCOMM. We
also increased our industrials exposure by adding to our position in Lockheed
Martin. Conversely, we reduced our consumer discretionary exposure by
eliminating our position in Johnson Controls and trimming our position in Home
Depot. Other notable buys and sells for the month include initiating a position
in utility, CMS Energy, and eliminating our position in American Tower, a U.S.
based real estate investment trust.
As at 28 February 2015, the Company's options exposure was 18.93% and the delta
of the options was 89.63%.
Positioning
The Company is currently overweight to the industrials, materials, consumer
discretionary and consumer staples sectors. We are underweight to the
financials, energy, health care, information technology and utilities sectors.
Despite relative underweights to financials, health care and information
technology, we have increased our exposure to these segments in recent months
given stronger fundamentals, the potential for dividend growth, and attractive
valuations.
17 March 2015
ENDS
Latest information is available by typing www.blackrock.co.uk/brna on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.